bufomix easyhaler innöndunarduft 160 míkróg/4,5 míkróg/skammt
orion corporation - budesonidum inn; formoterolum fúmarat - innöndunarduft - 160 míkróg/4,5 míkróg/skammt
bufomix easyhaler innöndunarduft 320 míkróg/9 míkróg/skammt
orion corporation - budesonidum inn; formoterolum fúmarat - innöndunarduft - 320 míkróg/9 míkróg/skammt
cardil (entrydil) forðatafla 120 mg
orion corporation - diltiazemum hýdróklóríð - forðatafla - 120 mg
veraloc retard forðatafla 200 mg
orion corporation - verapamilum hýdróklóríð - forðatafla - 200 mg
trilafon dekanoat (trilafon dekanoat) stungulyf, lausn 108 mg/ml
orion corporation - perphenazinum dekanóat - stungulyf, lausn - 108 mg/ml
corbilta (previously levodopa/carbidopa/entacapone sandoz)
orion corporation - algengari ddc hemli, ef - parkinsonsveiki - anti-parkinsonslyf - corbilta er ætlað til meðferðar hjá fullorðnum sjúklingum með parkinsonsveiki og skammtahreyfingar í upphafi skammts sem ekki eru stöðugir á meðferð með levodopa / dopa decarboxylasa (ddc).
stalevo (lyfjaver) filmuhúðuð tafla 150 mg/37,5 mg/200 mg
lyfjaver ehf. - levodopum inn; entacaponum inn; carbidopum inn - filmuhúðuð tafla - 150 mg/37,5 mg/200 mg
stalevo (lyfjaver) filmuhúðuð tafla 100 mg/25 mg/200 mg
lyfjaver ehf. - entacaponum inn; levodopum inn; carbidopum inn - filmuhúðuð tafla - 100 mg/25 mg/200 mg
tessie
orion corporation - tasipimidine sulfate - other hypnotics and sedatives - hundar - alleviation of situational anxiety and fear in dogs triggered by e. travel, noise, owner departure, veterinary visits.
nubeqa
bayer ag - darolutamide - stækkun Æxli, gelding-Þola - innkirtla meðferð - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5. - metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.